Cargando…

Predictors of Survival in Women with High-Risk Endometrial Cancer and Comparisons of Sandwich versus Concurrent Adjuvant Chemotherapy and Radiotherapy †

Background: to elucidate the predictors of progression-free survival (PFS) and overall survival (OS) in high-risk endometrial cancer patients. Methods: the medical records of all consecutivewomen with high-risk endometrial cancer were reviewed. Results: among 92 high-risk endometrial cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hui-Hua, Ting, Wan-Hua, Sun, Hsu-Dong, Wei, Ming-Chow, Lin, Ho-Hsiung, Hsiao, Sheng-Mou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459621/ https://www.ncbi.nlm.nih.gov/pubmed/32824293 http://dx.doi.org/10.3390/ijerph17165941

Ejemplares similares

A multi-institutional analysis of sequential versus ‘sandwich’ adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma
por: Onal, Cem, et al.
Publicado: (2018)

Predictors for the Recurrence of Clinically Uterine-Confined Endometrial Cancer and the Role of Cytokeratin Immunohistochemistry Stain in the Era of Sentinel Lymph Node Mapping
por: Ting, Wan-Hua, et al.
Publicado: (2022)

Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer
por: Abaid, Lisa N., et al.
Publicado: (2012)

Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
por: Wang, Shao-Jing, et al.
Publicado: (2022)

Adjuvant chemo-radiotherapy in the “sandwich” method for high risk endometrial cancer—a review of literature
por: Bie, Yachun, et al.
Publicado: (2015)

Controversies in the Adjuvant Therapy of Endometrial Cancer
por: Hsiao, Sheng-Mou, et al.
Publicado: (2011)

Sequential Chemotherapy and Radiotherapy in the Sandwich Method for Advanced Endometrial Cancer: A Meta-Analysis
por: Gao, Huiqiao, et al.
Publicado: (2015)

Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal versus Dose-Dense Platinum/Paclitaxel Chemotherapy without Bevacizumab
por: Ting, Wan-Hua, et al.
Publicado: (2020)

Adjuvant chemotherapy—Radiotherapy—Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases
por: Schliemann, Christoph, et al.
Publicado: (2018)

Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis
por: Winarto, Hariyono, et al.
Publicado: (2022)

Cervical Cancer Recurrence and Patient Survival After Radical Hysterectomy Followed by Either Adjuvant Chemotherapy or Adjuvant Radiotherapy With Optional Concurrent Chemotherapy: A Systematic Review and Meta-Analysis
por: Zhang, Yu-fei, et al.
Publicado: (2022)

Predictors of Lymphoceles in Women Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecologic Cancer: A Retrospective Cohort Study
por: Chen, Hui-Hua, et al.
Publicado: (2019)

Clinical and Urodynamic Predictors of the Q-Tip Test in Women With Lower Urinary Tract Symptoms
por: Wu, Chin-Jui, et al.
Publicado: (2020)

Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer
por: Tsai, Mu-Hung, et al.
Publicado: (2022)

IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma
por: Zhong, Qiulu, et al.
Publicado: (2017)

Manual versus Pump Infusion of Distending Media for Hysteroscopic Procedures: A Randomized Controlled Trial
por: Ting, Wan-Hua, et al.
Publicado: (2019)

Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy and intensity-modulated radiotherapy alone for stage II nasopharyngeal carcinoma
por: Chen, Kai-Hua, et al.
Publicado: (2016)

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial
por: Maggi, R, et al.
Publicado: (2006)

Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy
por: Foerster, Robert, et al.
Publicado: (2014)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2018)

Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy
por: Otsuka, I, et al.
Publicado: (2002)

The survival impact of adjuvant radiotherapy and chemotherapy in patients with non-endometrioid endometrial carcinomas: a PSM-IPTW analysis based on SEER database
por: Hao, Zhimin, et al.
Publicado: (2023)

Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study
por: Chen, Jenny Ling-Yu, et al.
Publicado: (2020)

Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma
por: Liang, Zhong-Guo, et al.
Publicado: (2017)

Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis
por: Rodrigues da Cunha Colombo Bonadio, Renata, et al.
Publicado: (2018)

CONcurrent ChEmotherapy and RadioTherapy in adjuvant treatment of breast cancer (CONCERT): a phase 2 study
por: Wadasadawala, Tabassum, et al.
Publicado: (2023)

The Effect of Adjuvant Chemotherapy on Survival in Patients with Residual Nasopharyngeal Carcinoma after Undergoing Concurrent Chemoradiotherapy
por: Yang, Shiping, et al.
Publicado: (2015)

The “Sandwich” Schedule: A Well-Tolerated Adjuvant Treatment Both in Intermediate–High- and High-Risk Endometrial Cancer
por: Ferrero, Annamaria, et al.
Publicado: (2022)

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.
por: Stål, O., et al.
Publicado: (1994)

Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival
por: McArdle, Colin S, et al.
Publicado: (2010)

Radiotherapy Alone Versus Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein–Barr Virus DNA after Induction Chemotherapy
por: Kong, Fangfang, et al.
Publicado: (2023)

Long-Term Follow-Up Results of Adjuvant Intensity-Modulated Radiotherapy with Concurrent Paclitaxel and Cisplatin in High-Risk Endometrial Cancer Patients
por: Shu, Pei, et al.
Publicado: (2022)

Adjuvant and first line chemotherapy use for endometrial cancer
por: Knisely, Anne, et al.
Publicado: (2022)

Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy
por: Zhang, Wei, et al.
Publicado: (2018)

Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study
por: Qiu, Wen-Ze, et al.
Publicado: (2016)

Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?
por: LeVasseur, N, et al.
Publicado: (2017)

MBCL-09. ISOLATED M1 METASTASES IN PEDIATRIC MEDULLOBLASTOMA: IS POSTOPERATIVE RADIOTHERAPY FOLLOWED BY MAINTENANCE CHEMOTHERAPY SUPERIOR TO POSTOPERATIVE SANDWICH-CHEMOTHERAPY AND RADIOTHERAPY?
por: Obrecht, Denise, et al.
Publicado: (2020)

Adjuvant Radiotherapy and/or Chemotherapy for Endometrial Cancer, Status as at 2019: Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO)
por: Emons, Günter, et al.
Publicado: (2019)

Improved disease-free survival with adjuvant radiotherapy in early-stage endometrial cancer: 10-year outcome analysis
por: Arslan, Suheyla Aytac, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u0fmq32psejro0lo6cn84238ad